Blog
Modern day Alchemy? Bisphosphonates – the Elixir of Life?
Through millennia, alchemists and dreamers have striven to formulate the elixir of immortality and have failed – dramatically, ignominiously, and sometimes tragically. It is interesting...
Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam
A Developing economy with a per-capita GDP of around $2,600 (2018 figures), Việt Nam is the 15th most populous country in the world. It has...
Speaking up for the ‘silent disease’ in the Asia Pacific
APCO round-up of World Osteoporosis Day 2020 activities Last Tuesday, October 20, 2020, members of the Asia Pacific Consortium on Osteoporosis (APCO) celebrated with...
Osteoporosis and fragility fractures – a family affair
Celebrating World Osteoporosis Day 2020 The Asia Pacific Consortium on Osteoporosis (APCO) is delighted to be celebrating World Osteoporosis Day (WOD) today (Tuesday, October...
Goal Directed Therapy in osteoporosis: a target in sight or still a pipe-dream?
“Goal Directed Therapy” (GDT) is a patient care approach designed to improve patient outcomes, and is well established following its initial introduction in critical care....
Breakable bones and genes – How can doctors utilise genes for fracture risk assessment?
More than 300 genetic variants have been discovered to be associated with osteoporosis or fracture. The magnitude of effect of these variants on fracture risk...
Innovative approaches to driving public awareness of bone health
In December 2012, Osteoporosis New Zealand (ONZ) published BoneCare 2020 which called for implementation of a systematic approach to hip fracture care and prevention for...
Osteopenia – To treat or not to treat. That is the question
Osteopenia is not a disease. It is a category of bone density - between 1 and 2.5 standard deviations below the mean value in the...
